The Central Pharmaceutical Affairs Review Committee, an expert advisory body for the MFDS, recommended the approval of Pfizer's COVID-19 vaccine. They gathered opinions that it is possible to administer them even over the age of 16.

The MFDS explained the results by announcing the results of the Central Pharmaceutical Affairs Review Committee meeting held on the 25th.

This Central Pharmaceutical Affairs Review Committee meeting is held with 19 external experts including 13 standing members of the Biopharmaceutical Subcommittee, which is a specialized subcommittee for deliberation on the safety and effectiveness of vaccines, 5 verification advisory members, and 1 expert recommended by the